MedTrace Logo

Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)

NCT01870557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 197

Last updated 2015-05-28

No results posted yet for this study

Summary

Objective To collate the bone status in type 1 and type 2 diabetics using biochemical markers and bone scans.

Methods:

This is a multicenter trial involving the University Hospitals of three major danish cities: Aalborg, Aarhus and Odense. The trial is of cross-sectional design and consists of examinations including:

* Blood samples to analyze bone markers, glycemic state, kidney function and sex-hormones.
* 24 hour urine sample to analyze bone markers and kidney function.
* Bone scans including dual energy x-ray absorptiometry (DXA) and high resolution peripheral quantitative computed tomography (HRpQCT) to evaluate Bone Mineral Density, t-score and bone structure.

Participants:

100 type 1 diabetics and 100 type 2 diabetics recruited from outpatient clinics at Aalborg, Aarhus and Odense, general practitioners and flyers.

Conditions

Sponsors & Collaborators

  • Jakob Starup Linde

    lead OTHER

Principal Investigators

  • Peter Vestergaard, Professor MD PhD DrMedSc · Aalborg University Hospital

  • Kim Brixen, Professor MD PhD DrMedSc · Odense University Hospital

  • Søren Gregersen, MD PhD · Aarhus University Hospital

  • Bente Lomholt Langdahl, Professor MD PhD DrMedSc · Aarhus University Hospital

  • Ellen-Magrethe Hauge, MD PhD · Aarhus University Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-12-31
Completion
2015-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01870557 on ClinicalTrials.gov